Home Newsfeeds Macquarie Maintains Underperform on Netflix, Raises Price Target to $170

Macquarie Maintains Underperform on Netflix, Raises Price Target to $170

Macquarie analyst Tim Nollen maintains Netflix (NASDAQ:NFLX) with a Underperform and raises the price target from $150 to $170.

byBenzinga Newsdesk

July 20, 2022

1 minute read

Macquarie analyst Tim Nollen maintains Netflix (NASDAQ:NFLX) with a Underperform and raises the price target from $150 to $170.

uniQure’s Hemgenix Royalty Sales Agreement Extends Cash Runway, Relieves Near-Term Commercial Risk, Says Analyst

By Vandana Singh

May 15, 1:35 PM

uniQure N.V. (NASDAQ: QURE) agreed to sell a portion of the royalty rights due from CSL Behring from Hemgenix (etranacogene dezaparvovec-drbl) net sales to HealthCare Royalty and Sagard Healthcare

QURE

HP Q4 EPS $0.85 Down From $0.94 YoY, Sales $14.80B Down From $16.68B YoY

By Benzinga Newsdesk

November 22, 5:15 PM

HP (NYSE:HPQ) reported quarterly earnings of $0.85 per share. This is a 9.57 percent decrease over earnings of $0.94 per share from the same period last year. The company reported $14.80 billion in sales this quarter.

HPQ

3M’s Litigation Concerning Defective Earplug Injuries To US Veterans Mark Another Tough Loss Amid Multiple Lawsuits: Analyst

By Anusuya Lahiri

December 27, 1:12 PM

Mizuho analyst Brett Linzey maintained a Hold rating on 3M Company (NYSE: MMM) with a price target of $130.00.

MMM

Apple Analyst Reduces FY23 Estimates Citing Macro, Supply Chain And Geo-Political Headwinds

By Anusuya Lahiri

December 22, 5:19 PM

Needham analyst Laura Martin reiterated Buy on Apple Inc (NASDAQ: AAPL) with a $170 price target. Martin reduced FY23 estimates for AAPL. The analyst now projects just 2% revenue growth and lower EPS Y/Y in FY23.

AAPL

Macquarie Maintains Underperform on Netflix, Raises Price Target to $170

Related Posts

uniQure’s Hemgenix Royalty Sales Agreement Extends Cash Runway, Relieves Near-Term Commercial Risk, Says Analyst

HP Q4 EPS $0.85 Down From $0.94 YoY, Sales $14.80B Down From $16.68B YoY

3M’s Litigation Concerning Defective Earplug Injuries To US Veterans Mark Another Tough Loss Amid Multiple Lawsuits: Analyst

Apple Analyst Reduces FY23 Estimates Citing Macro, Supply Chain And Geo-Political Headwinds